130 related articles for article (PubMed ID: 12607560)
21. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
22. TGF-β signaling in development and disease.
Massagué J
FEBS Lett; 2012 Jul; 586(14):1833. PubMed ID: 22651913
[No Abstract] [Full Text] [Related]
23. Inhibitory machinery for the TGF-β family signaling pathway.
Itoh S; Itoh F
Growth Factors; 2011 Oct; 29(5):163-73. PubMed ID: 21913798
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Smad phosphorylation and Smad-receptor interaction.
Mehra A; Attisano L; Wrana JL
Methods Mol Biol; 2000; 142():67-78. PubMed ID: 10806614
[No Abstract] [Full Text] [Related]
25. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
26. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
Beall MJ; McGonigle S; Pearce EJ
Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
[TBL] [Abstract][Full Text] [Related]
27. Intracellular signaling: Fleshing out the TGFbeta pathway.
Padgett RW
Curr Biol; 1999 Jun; 9(11):R408-11. PubMed ID: 10359694
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta receptor signaling.
Derynck R; Feng XH
Biochim Biophys Acta; 1997 Oct; 1333(2):F105-50. PubMed ID: 9395284
[No Abstract] [Full Text] [Related]
30. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling.
Sekiya T; Oda T; Matsuura K; Akiyama T
Biochem Biophys Res Commun; 2004 Jul; 320(3):680-4. PubMed ID: 15240101
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall.
Wang M; Zhao D; Spinetti G; Zhang J; Jiang LQ; Pintus G; Monticone R; Lakatta EG
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1503-9. PubMed ID: 16690877
[TBL] [Abstract][Full Text] [Related]
33. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
[TBL] [Abstract][Full Text] [Related]
34. A transforming growth factor beta type I receptor that signals to activate gene expression.
Bassing CH; Yingling JM; Howe DJ; Wang T; He WW; Gustafson ML; Shah P; Donahoe PK; Wang XF
Science; 1994 Jan; 263(5143):87-9. PubMed ID: 8272871
[TBL] [Abstract][Full Text] [Related]
35. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.
Tan M; Wang Y; Guan K; Sun Y
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):109-14. PubMed ID: 10618379
[TBL] [Abstract][Full Text] [Related]
36. Genetic and biochemical analysis of TGF beta signal transduction.
Padgett RW; Savage C; Das P
Cytokine Growth Factor Rev; 1997 Mar; 8(1):1-9. PubMed ID: 9174659
[TBL] [Abstract][Full Text] [Related]
37. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
38. Mammalian antiproliferative signals and their targets.
Massagué J; Polyak K
Curr Opin Genet Dev; 1995 Feb; 5(1):91-6. PubMed ID: 7749332
[TBL] [Abstract][Full Text] [Related]
39. [Transforming growth factor-beta signaling and cancer].
Miyazono K
Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
[TBL] [Abstract][Full Text] [Related]
40. Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility.
Budi EH; Duan D; Derynck R
Trends Cell Biol; 2017 Sep; 27(9):658-672. PubMed ID: 28552280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
